These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 29554495)

  • 21. Dendritic Cell-Based Cancer Vaccines.
    Santos PM; Butterfield LH
    J Immunol; 2018 Jan; 200(2):443-449. PubMed ID: 29311386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Tumor Antigens and Cancer Immunotherapy.
    Vigneron N
    Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses.
    Vermaelen K
    Front Immunol; 2019; 10():8. PubMed ID: 30723469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in Vaccine Therapies for Breast Cancer.
    Li X; Bu X
    Adv Exp Med Biol; 2017; 1026():315-330. PubMed ID: 29282691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel era of cancer/testis antigen in cancer immunotherapy.
    Meng X; Sun X; Liu Z; He Y
    Int Immunopharmacol; 2021 Sep; 98():107889. PubMed ID: 34174699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-13 receptor-directed cancer vaccines and immunotherapy.
    Nakashima H; Husain SR; Puri RK
    Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells.
    Ramachandran M; Dimberg A; Essand M
    Semin Cancer Biol; 2017 Aug; 45():23-35. PubMed ID: 28257957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide-based vaccines for cancer therapy.
    Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
    Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities.
    Shemesh CS; Hsu JC; Hosseini I; Shen BQ; Rotte A; Twomey P; Girish S; Wu B
    Mol Ther; 2021 Feb; 29(2):555-570. PubMed ID: 33038322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.
    Bol KF; Schreibelt G; Gerritsen WR; de Vries IJ; Figdor CG
    Clin Cancer Res; 2016 Apr; 22(8):1897-906. PubMed ID: 27084743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress and prospects in vaccine therapy for gynecologic cancers.
    Gurski KJ; Steller MA
    Oncology (Williston Park); 1997 Nov; 11(11):1727-34, 1739-40; discussion 1740,. PubMed ID: 9394368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
    Van den Eynde B
    Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer immunotherapy: moving forward with peptide T cell vaccines.
    Kumai T; Fan A; Harabuchi Y; Celis E
    Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.
    Grau M; Walker PR; Derouazi M
    Cell Mol Life Sci; 2018 Aug; 75(16):2887-2896. PubMed ID: 29508006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor vaccines-therapeutic vaccination against cancer].
    Rammensee HG; Löffler MW; Walz JS; Bokemeyer C; Haen SP; Gouttefangeas C
    Internist (Berl); 2020 Jul; 61(7):690-698. PubMed ID: 32462251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
    Jäger E; Jäger D; Knuth A
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.